Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
101,224,395
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
70,332,894
-
Shares change
-
+1,396,925
-
Total reported value, excl. options
-
$2,323,064,829
-
Value change
-
+$51,308,447
-
Put/Call ratio
-
250%
-
Number of buys
-
130
-
Number of sells
-
61
-
Price
-
$33.04
Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM) as of Q1 2024
As of 31 Mar 2024 Beam Therapeutics Inc. - COMMON STOCK (BEAM) had 259 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 70,332,894 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, FARALLON CAPITAL MANAGEMENT LLC, MORGAN STANLEY, STATE STREET CORP, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., and MWG Management Ltd..
This table shows 259 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.